K. G. Jebsen TREC - Thrombosis Research and Expertise Center

The vision of TREC is to diminish patient suffering and burden of venous thrombosis in the society by discovering novel risk factors and disease mechanisms.

The Center is financed by the K.G. Jebsen Foundation, UiT- The Arctic University of Norway and the Northern Norway Regional Health Authority. Read more about TREC



Are clot risks in the genes of cancer patients?

A new TREC study has looked into the role of genes on the risk of blood clots in cancer patients


Low-grade inflammation and future risk of venous thromboembolism - does a relationship exist?

Inflammation is a risk factor for venous thromboembolism. We have investigated wheter a certain infammatory marker is associated with future venous thromboembolism.


Hospital-related venous thrombosis and risk of recurrence

Hospitalization is a well-known risk factor for venous thrombosis, but the risk of recurrence after hospital-related incidents is uncertain. Recently, we at K.G. Jebsen TREC may have shed some light on this matter.


Does variation in the size of the red blood cells cause increased formation of atherosclerotic plaques?

A recent study from K.G. Jebsen TREC shows an association between the size variation of the red blood cells, and increased progression of atherosclerosis.


Do the distribution of blod cells increase the risk of Venous thrombosis?

Findings from K. G. Jebsen TREC suggests that high red blood cell distribution width (RDW) is a risk factor of Venous thromboembolism (VTE), and that RDW is a predictor of all-cause mortality in VTE-patients.


Obesity, myocardial infarction and venous thrombosis – shared risk factor, different mechanisms?

TREC findings suggest that the pattern of body fat distribution and the metabolic changes in obesity have differential impact on the risk of venous and arterial thrombosis


Do compression stockings provide pain relief after a deep vein thrombosis?

Results from a recent study suggest that compression stockings do not provide pain relief
after a deep vein thrombosis


Is the risk of venous thromboembolism in carriers of a prothrombin mutation influenced by high levels of microparticles?

Venous thromboembolism (VTE) is a complex disorder where several risk factors, including environmental, lifestyle, and genetic factors, play a part. Prothrombin gene mutation (PTM) is one of the most common genetic polymorphisms known to predispose carriers to VTE. PTM is found in 5% to 10% of patients with VTE. PTM results in an increased level of prothrombin in the blood and prothrombin plays a key role in the clotting cascade.


The first TREC exchange student

My name is Huang Chi Wei. I am a fourth year medical student from Taiwan. I came to Tromsø and K.G. Jebsen TREC for one month as an exchange student to get basic lab experience.


Visit us:

Our strategy 



Visiting address:

3rd floor at The Pharmacy building

Mail address:

K.G. Jebsen TREC
The Faculty of Health Sciences
UiT- The Arctic University of Norway
9037 Tromsø